Factors for Impairment of Renal Graft Function in Intensive Care
NCT ID: NCT06191146
Last Updated: 2024-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2024-01-01
2025-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
the aim is to identify risk factors for renal graft degradation in the ICU up to 2 years after hospitalization.
Optimization of renal graft management in the ICU and management by nephrologists after the ICU
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development and Validation of a Clinical Risk Prediction Model for Early Acute Kidney Injury Within 48 Hours After Liver Transplantation
NCT06750770
Resistive Index Measurements After Kidney Transplantation
NCT01879124
HOW DOES HEMODYNAMIC REGULATION AFFECTS GRAFT FUNCTIONS DURING RENAL TRANSPLANTATION?
NCT05753475
The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient
NCT01457534
Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management
NCT03997253
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years
* first hospitalization in ICU
Exclusion Criteria
* transfer to intensive care immediately after transplant within 24 hours
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gibot Sébastien
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sébastien GIBOT
Role: PRINCIPAL_INVESTIGATOR
CHU NANCY Central
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Nancy
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
sebastien gibot, md
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023PI048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.